References
- Sutherland IH, Campbell WC. Development, pharmacokinetics and mode of action of ivermectin. Acta Leiden 1990; 59:161–168.
- Campbell WC, Fisher MH, Stapley EO, Albers-Schonberg G, Jacob TA. Ivermectin: a potent new antiparasitic agent. Science 1983; 221:823–828.
- Yen TH, Lin JL. Acute poisoning with emamectin benzoate. J Toxicol Clin Toxicol 2004; 42:657–661.
- Lankas GR, Gordon LR. Toxicology. In: Campbell WC, ed. Ivermectin and Abamectin. New York: Springer, 1989:89–112.
- Chung K, Yang CC, Wu ML, Deng JF, Tsai WJ. Agricultural avermectins: an uncommon but potentially fatal cause of pesticide poisoning. Ann Emerg Med 1999; 34:51–57.
- Snodgrass SR. Myoclonus: analysis of monoamine, GABA, and other systems. FASEB J 1990; 4:2775–2788.
- Magnaghi V, Ballabio M, Camozzi F, Colleoni M, Consoli A, Gassmann M, Lauria G, Motta M, Procacci P, Trovato AE, Bettler B. Altered peripheral myelination in mice lacking GABA B receptors. Mol Cell Neurosci 2008; 37:599–609.
- Thongsinthusak T, Ross J, Fong H, Formoli T, Krieger R. Estimation of exposure of persons in California to pesticide products that contain abamectin. HS-1567. Sacramento: California Department of Food and Agriculture; 1990.
- Bunc M, Pezdir T, Mozina H, Mozina M, Brvar M. Butanol ingestion in an airport hangar. Hum Exp Toxicol 2006; 25:195–197.
- Moshe S, Bitchatchi E, Goshen J, Attias J. Neuropathy in an artist exposed to organic solvents in paints: a case study. Arch Environ Health 2002; 57:127–129.
- Visser LH. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol 2006; 13:1203–1212.